Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns ...

Vaccine expert Hu Haitao, who studied under Drew Weissman, the Nobel laureate and pioneer of mRNA biology, has given up his ...

A therapy based on messenger RNA (mRNA), a genetic material actively studied for vaccines and other applications, has turned ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Penn State researchers discovered that two proteins within the CCR4-NOT complex have opposing effects on mRNA stability.

Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction ...

PHILADELPHIA – An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve ...

Stanford researchers have identified a biological pathway that helps explain why mRNA COVID-19 vaccines can, in very rare cases, trigger short-lived heart inflammation in younger males, while also ...